Summary
Updated Aug 30, 2026
Corleen M. Roche is Chief Financial Officer of IOVANCE BIOTHERAPEUTICS, INC. (IOVA). 4 SEC Form 4 filings on record going back to 2024, most recently on 10 August 2026.
Recent Transactions
2Every recent SEC Form 4 transaction Corleen M. Roche has reported, most recent first.
Other Insiders Active in the Same Stocks
Insiders who have reported open-market trades at the same companies as Corleen M. Roche. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- Ryan D. Maynard - $503K of IOVA open-market activity on record
More Notable Insiders
Other corporate insiders with significant SEC Form 4 track records on InsiderAlpha:
Frequently Asked Questions
Who is Corleen M. Roche?
Corleen M. Roche is a corporate insider, tracked as Chief Financial Officer of IOVANCE BIOTHERAPEUTICS, INC. (IOVA). InsiderAlpha holds 4 primary Form 4 filings for them, the earliest from 2024, updated as new SEC EDGAR filings are processed.
How many SEC Form 4 filings has Corleen M. Roche submitted recently?
1 primary Form 4 filing in the last 90 days, covering 1 company.
Where can I see all of Corleen M. Roche's SEC filings?
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Learn More
Follow Corleen M. Roche and every insider like them
A free account opens the full scored daily plan and every past day, a watchlist for any ticker, and 3 months of price history on every company page. No card.
Free plan available · Paid plans start with a 7-day free trial
